Substance / Medication

Foscarnet

Overview

Active Ingredient
foscarnet
RxNorm CUI
33562

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

5 trials linked to this intervention

5
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection.
Han Yan-Xing, Xue Rong, Zhao Wei et al. · Antiviral Res · 2005
PMID: 16280177RCT
Foscarnet Versus Ganciclovir for Severe Congenital Cytomegalovirus Infection: Short- and Long-Term Follow-Up.
Nigro Giovanni, Buzzi Marta, Catenaro Milena et al. · Viruses · 2025
PMID: 40431731ObservationalFull text (PMC)
Continuous-Infusion Foscarnet Facilitates Administration in Hematopoietic Stem Cell Transplantation Patients.
Domingo Walter, Nguyen Isabelle T, Johnsrud Joyce J et al. · Transplant Cell Ther · 2021
PMID: 33891883Observational
Recommended foscarnet dose is not associated with improved outcomes in cytomegalovirus salvage therapy.
Spinner Michael L, Lam Simon W, Koval Christine E et al. · J Clin Virol · 2019
PMID: 31514101Observational
Long-term foscarnet therapy remodels thymidine analogue mutations and alters resistance to zidovudine and lamivudine in HIV-1.
Mathiesen Sofie, Dam Elisabeth, Roge Birgit et al. · Antivir Ther · 2007
PMID: 17591023Observational
[Foscarnet sodium for treatment in patients with severe chronic hepatitis B].
Yu Yan-yan, Zhang Da-zhi, Miao Xiao-hui et al. · Zhonghua Gan Zang Bing Za Zhi · 2006
PMID: 17125606Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Foscarnet (substance)
SNOMED CT
372902006
UMLS CUI
C0070895
RxNorm CUI
33562

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
5
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.